Moods Disorders Recruiting Phase 3 Trials for Celecoxib (DB00482)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02703363Minocycline and Celecoxib as Adjunctive Treatments of Bipolar DepressionTreatment